APA (7th ed.) Citation

Schwabe, C., Cole, A., Espigares‐Correa, A., Beydon, M. E., Florez‐Igual, A., & Queiruga‐Parada, J. (2023). A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab. Pharmacology research & perspectives, 11(2), e01070-n/a. https://doi.org/10.1002/prp2.1070

Chicago Style (17th ed.) Citation

Schwabe, C., A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, and J. Queiruga‐Parada. "A Randomized, Double‐blind, Single‐dose Study to Assess Bioequivalence of MB02 Biosimilar After Manufacturing Iteration and Reference Bevacizumab." Pharmacology Research & Perspectives 11, no. 2 (2023): e01070-n/a. https://doi.org/10.1002/prp2.1070.

MLA (9th ed.) Citation

Schwabe, C., et al. "A Randomized, Double‐blind, Single‐dose Study to Assess Bioequivalence of MB02 Biosimilar After Manufacturing Iteration and Reference Bevacizumab." Pharmacology Research & Perspectives, vol. 11, no. 2, 2023, pp. e01070-n/a, https://doi.org/10.1002/prp2.1070.